{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:17:24Z","timestamp":1777407444943,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2019Y0060"],"award-info":[{"award-number":["2019Y0060"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s11605-022-05421-x","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T10:25:13Z","timestamp":1659522313000},"page":"2292-2300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Comparison of Arterial Infusion Chemotherapy and Chemoembolization for Locally Advanced Hepatocellular Carcinoma: a Multicenter Retrospective Study"],"prefix":"10.1016","volume":"26","author":[{"given":"Shiguang","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenchang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengjian","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanben","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s11605-022-05421-x_bb0010","first-page":"115","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin."},{"key":"10.1007\/s11605-022-05421-x_bb0015","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1111\/liv.12818","article-title":"Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE study","volume":"35","author":"Park","year":"2015","journal-title":"Liver Int"},{"key":"10.1007\/s11605-022-05421-x_bb0020","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1159\/000509424","article-title":"Guidelines for diagnosis and treatment of hepatocellular carcinoma (2019 edition)","volume":"9","author":"Zhou","year":"2020","journal-title":"Liver Cancer"},{"issue":"Supplement 1","key":"10.1007\/s11605-022-05421-x_bb0025","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1053\/j.gastro.2004.09.032","article-title":"Chemoembolization for hepatocellular carcinoma","volume":"127","author":"Bruix","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1007\/s11605-022-05421-x_bb0030","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/BF00402774","article-title":"Experiments on the efficacy and toxicity of locoregional chemotherapy of liver tumors with 5-fluoro-2\u2032-deoxyuridine (FUDR) and 5-fluorouracil (5-FU) in an animal model","volume":"111","author":"Bartkowski","year":"1986","journal-title":"J Cancer Res Clin Oncol."},{"key":"10.1007\/s11605-022-05421-x_bb0035","first-page":"4724","article-title":"Regional pharmacokinetics of 5-bromo-2\u2032-deoxyuridine and 5-fluorouracil in dogs: hepatic arterial versus portal venous infusions","volume":"56","author":"Kuan","year":"1996","journal-title":"Cancer Res."},{"key":"10.1007\/s11605-022-05421-x_bb0040","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000367746","article-title":"Current status of hepatic arterial infusion chemotherapy","volume":"4","author":"Obi","year":"2015","journal-title":"Liver Cancer"},{"key":"10.1007\/s11605-022-05421-x_bb0045","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1038\/bjc.2013.542","article-title":"Effect of hepatic arterial infusion chemotherapy of 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma in the Nationwide Survey of Primary Liver Cancer in Japan","volume":"109","author":"Nouso","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1007\/s11605-022-05421-x_bb0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000514174","article-title":"Management of hepatocellular carcinoma in Japan: JSH consensus statements and recommendations 2021 update","volume":"10","author":"Kudo","year":"2021","journal-title":"Liver Cancer."},{"key":"10.1007\/s11605-022-05421-x_bb0055","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejca.2020.03.032","article-title":"Hepatic arterial infusion of oxaliplatin plus raltitrexed in patients with intermediate and advanced stage hepatocellular carcinoma: a phase II, single-arm, prospective study","volume":"134","author":"Chen","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1007\/s11605-022-05421-x_bb0060","unstructured":"Li QJ, He MK, Chen HW, et al. Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial. J Clin Oncol 2021: JCO2100608."},{"key":"10.1007\/s11605-022-05421-x_bb0065","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1007\/s11605-022-05421-x_bb0070","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/hepr.13620","article-title":"Comparison of the efficacy and safety of conventional transarterial chemoembolization with and without drug-eluting beads embolization for the treatment of unresectable large hepatocellular carcinoma","volume":"51","author":"Chen","year":"2021","journal-title":"Hepatology Research."},{"key":"10.1007\/s11605-022-05421-x_bb0075","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1007\/s11605-022-05421-x_bb0080","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Llovet JM Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis."},{"key":"10.1007\/s11605-022-05421-x_bb0085","doi-asserted-by":"crossref","first-page":"65577","DOI":"10.18632\/oncotarget.11576","article-title":"The use of and adherence to CTCAEv3.0 in cancer clinical trial publications","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1007\/s11605-022-05421-x_bb0090","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm Stat."},{"key":"10.1007\/s11605-022-05421-x_bb0095","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"10.1007\/s11605-022-05421-x_bb0100","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3350\/kjhep.2010.16.4.355","article-title":"A comparative study of high-dose hepatic arterial infusion chemotherapy and transarterial chemoembolization using doxorubicin for intractable, advanced hepatocellular carcinoma","volume":"16","author":"Kim","year":"2010","journal-title":"Korean J Hepatol."},{"key":"10.1007\/s11605-022-05421-x_bb0105","doi-asserted-by":"crossref","first-page":"e21489","DOI":"10.1097\/MD.0000000000021489","article-title":"Hepatic arterial infusion chemotherapy vs transcatheter arterial embolization for patients with huge unresectable hepatocellular carcinoma","volume":"99","author":"Tsai","year":"2020","journal-title":"Med (Baltim)."},{"key":"10.1007\/s11605-022-05421-x_bb0110","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1148\/rg.336125104","article-title":"Hepatocellular carcinoma: illustrated guide to systematic radiologic diagnosis and staging according to guidelines of the American Association for the Study of Liver Diseases","volume":"33","author":"McEvoy","year":"2013","journal-title":"RadioGraphics"},{"key":"10.1007\/s11605-022-05421-x_bb0115","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"European Association for the Study of the Liver","year":"2018","journal-title":"J Hepatol."},{"key":"10.1007\/s11605-022-05421-x_bb0120","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.3748\/wjg.v22.i32.7289","article-title":"Management of hepatocellular carcinoma with portal vein tumor thrombosis: review and update at 2016","volume":"22","author":"Chan","year":"2016","journal-title":"World J Gastroenterol."},{"key":"10.1007\/s11605-022-05421-x_bb0125","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamaoncol.2019.0250","article-title":"Sorafenib plus hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin vs sorafenib alone for hepatocellular carcinoma with portal vein invasion: a randomized clinical trial","volume":"5","author":"He","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1007\/s11605-022-05421-x_bb0130","doi-asserted-by":"crossref","first-page":"619461","DOI":"10.3389\/fonc.2021.619461","article-title":"Hepatic arterial infusion chemotherapy of oxaliplatin, fluorouracil, and leucovorin with or without sorafenib as initial treatment for advanced hepatocellular carcinoma","volume":"11","author":"Liang","year":"2021","journal-title":"Front Oncol."}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-022-05421-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11605-022-05421-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23014890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23014890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-022-05421-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:07:40Z","timestamp":1761077260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X23014890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1091255X23014890"],"URL":"https:\/\/doi.org\/10.1007\/s11605-022-05421-x","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Arterial Infusion Chemotherapy and Chemoembolization for Locally Advanced Hepatocellular Carcinoma: a Multicenter Retrospective Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s11605-022-05421-x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 Society for Surgery of the Alimentary Tract. Published by ELSEVIER INC. All rights reserved. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}